Moderna Seeks OK For Emergency Approval For COVID Vaccine, Now What?

The transcript discusses the progress of COVID-19 vaccines by Moderna and Pfizer, highlighting Moderna's 94% efficacy in trials and the use of mRNA technology. Both vaccines are seeking FDA emergency use authorization. The approval process involves regulatory reviews, with Pfizer's hearing on December 10th and Moderna's on December 17th. Initial vaccine doses will be limited, with broader availability expected by mid-next year. Public health measures like mask-wearing remain crucial until widespread vaccine distribution. A CDC Advisory Board will decide on vaccine prioritization.

What technology does Moderna's COVID-19 vaccine use to generate an immune response?

• Viral vector

• mRNA technology

• Protein subunit

• DNA technology

When is the FDA hearing for Pfizer's vaccine scheduled?

• December 10th

• December 17th

• December 25th

• December 1st

How many doses does Moderna expect to have ready for the US by the end of the year?

• 15 million

• 20 million

• 25 million

• 10 million

What is the expected timeline for the majority of Americans to receive the COVID-19 vaccine?

• End of this year

• First quarter of next year

• Fourth quarter of next year

• Second or third quarter of next year

What preventive measure is recommended until the vaccine is widely distributed?

• Avoid outdoor activities

• Stop using public transport

• Wear a mask

• Only eat at home